United Therapeutics has committed up to $25 million over five years to launch a xenoliver research center at Baylor College of Medicine, deepening a Houston footprint anchored by its nearly $100 million gene-edited swine campus in the Generation Park development.
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Signup for news and special announcements!
You have successfully joined our subscriber list.
Vacancy in Houston's largest industrial buildings has fallen to between 2.3 percent...
ByThe RegistryNovember 1, 2026A new Texas A&M economic outlook shows Texas adding jobs at more...
ByThe RegistryNovember 1, 2026Houston's West and Southwest industrial submarkets ended the third quarter of 2026...
ByThe RegistryNovember 1, 2026Prologis' third-quarter results put Dallas-Fort Worth and Houston at the front of...
ByThe RegistryNovember 1, 2026Error: Contact form not found.